Market Research Logo

Europe Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

Europe Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Multiple Myeloma patients study in a new report ‘Europe Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Myeloma derived from epidemiological analysis, percentage of patients diagnosed with Multiple Myeloma, and percentage of patients treated with a therapy.

The study helps executives estimate Multiple Myeloma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Multiple Myeloma prevalence, Multiple Myeloma diagnosis rate, and Multiple Myeloma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Multiple Myeloma Patient Flow
  • Multiple Myeloma Prevalence
  • Multiple Myeloma Diagnosed Patients
  • Multiple Myeloma Treated Patients


1. Multiple Myeloma: Disease Definition
2. Multiple Myeloma Patient Flow in Europe
2A. Multiple Myeloma Prevalence in Europe
2B. Multiple Myeloma Diagnosed Patients in Europe
2C. Multiple Myeloma Treated Patients in Europe
3. Multiple Myeloma Patient Flow in Germany
3A. Multiple Myeloma Prevalence in Germany
3B. Multiple Myeloma Diagnosed Patients in Germany
3C. Multiple Myeloma Treated Patients in Germany
4. Multiple Myeloma Patient Flow in France
4A. Multiple Myeloma Prevalence in France
4B. Multiple Myeloma Diagnosed Patients in France
4C. Multiple Myeloma Treated Patients in France
5. Multiple Myeloma Patient Flow in Spain
5A. Multiple Myeloma Prevalence in Spain
5B. Multiple Myeloma Diagnosed Patients in Spain
5C. Multiple Myeloma Treated Patients in Spain
6. Multiple Myeloma Patient Flow in Italy
6A. Multiple Myeloma Prevalence in Italy
6B. Multiple Myeloma Diagnosed Patients in Italy
6C. Multiple Myeloma Treated Patients in Italy
7. Multiple Myeloma Patient Flow in UK
7A. Multiple Myeloma Prevalence in UK
7B. Multiple Myeloma Diagnosed Patients in UK
7C. Multiple Myeloma Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Multiple Myeloma Patient Flow in Europe, 2016
Table 2: Multiple Myeloma Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Multiple Myeloma Patient Flow in Germany, 2016
Table 4: Multiple Myeloma Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Multiple Myeloma Patient Flow in France, 2016
Table 6: Multiple Myeloma Patient Flow Forecast in France, 2016 - 2025
Table 7: Multiple Myeloma Patient Flow in Spain, 2016
Table 8: Multiple Myeloma Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Multiple Myeloma Patient Flow in Italy, 2016
Table 10: Multiple Myeloma Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Multiple Myeloma Patient Flow in UK, 2016
Table 12: Multiple Myeloma Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Multiple Myeloma Patient Flow in Europe, 2016
Figure 2: Multiple Myeloma Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Multiple Myeloma Patient Flow in Germany, 2016
Figure 4: Multiple Myeloma Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Multiple Myeloma Patient Flow in France, 2016
Figure 6: Multiple Myeloma Patient Flow Forecast in France, 2016 - 2025
Figure 7: Multiple Myeloma Patient Flow in Spain, 2016
Figure 8: Multiple Myeloma Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Multiple Myeloma Patient Flow in Italy, 2016
Figure 10: Multiple Myeloma Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Multiple Myeloma Patient Flow in UK, 2016
Figure 12: Multiple Myeloma Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report